Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals
- 24 August 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Research in Cardiology
- Vol. 107 (1), 30-41
- https://doi.org/10.1007/s00392-017-1155-5
Abstract
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, which goes along with increased risk for sudden cardiac death (SCD). Despite the knowledge about the different causal genes, the relationship between individual genotypes and phenotypes is incomplete.Keywords
This publication has 79 references indexed in Scilit:
- Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in miceJournal of Molecular and Cellular Cardiology, 2012
- The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic Resonance, 2012
- Unexpectedly low mutation rates in beta‐myosin heavy chain and cardiac myosin binding protein genes in italian patients with hypertrophic cardiomyopathyJournal of Cellular Physiology, 2011
- Genetics and Clinical Destiny: Improving Care in Hypertrophic CardiomyopathyCirculation, 2010
- Myocardial Fibrosis as an Early Manifestation of Hypertrophic CardiomyopathyNew England Journal of Medicine, 2010
- Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic CardiomyopathyBMC Medical Genetics, 2010
- Hypertrophic CardiomyopathyHeart Failure Clinics, 2010
- Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relativesHuman Mutation, 2008
- Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in miceJCI Insight, 2008
- Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3geneBMC Medical Genetics, 2008